WASHINGTON – The Food and Drug Administration is proposing a new classification for a product that’s existed in a legal grey area for years, a win for proponents of dietary supplements, including members of the MAHA movement.
The proposed rule would classify N-acetyl-L-cysteine, known as NAC and already widely sold over-the-counter, as the agency’s first “Dietary Ingredient Not Excluded from the Dietary Supplement Definition” — in essence, not not a supplement.
The need for the legal backbending stems from the fact that the FDA previously approved NAC as a drug, and FDA regulations prohibit the agency from including approved drugs in the dietary supplement category. In 1963, the agency approved NAC to break up mucus in certain lung conditions, and in 1974 to treat acetaminophen overdose.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.
Already have an account? Log in
Source: www.statnews.com



